99% pure – but 99% of what? Understanding peptide purity

A research peptide can come with a 99% purity figure, but the number is easy to read too literally. It does not necessarily mean that 99% of everything in the vial is the target peptide and the remaining 1% is impurity. Usually, the figure comes from an analytical technique such as high-performance liquid chromatography (HPLC). What HPLC reports is tied to what the method can separate and detect under the conditions used. Total peptide by weight is another question. So are identity and substances that require their own analytical tests. This makes the familiar 99% figure less self-explanatory than it first appears. To make sense of it, you need to know what was measured. What peptide purity actually means Peptide purity generally refers to the proportion of the target peptide relative to detectable peptide-related impurities in an analytical measurement. With HPLC, the calculation is commonly based on the areas of the peaks in the chromatogram. In simplified form: HPLC purity (%) = main peptide peak area / total relevant integrated peak area × 100 Suppose the main peak accounts for 99% of the relevant integrated signal. That can support a reported HPLC purity of 99%. It still does not mean that the target peptide makes up 99% of the total weight inside the vial. Purity is only one measurement. Other terms that often appear alongside it describe something different: Identity – whether the material corresponds to the expected peptide. Peptide content or assay – how much peptide material is present. Net peptide content – the amount of peptide material in the sample, excluding non-peptide components such as residual water and counterions. Concentration – the amount of a substance in a given volume or quantity of mixture. This is why a highly pure chromatographic research peptide sample can still have a lower net peptide content. There is no contradiction between the two figures. Where peptide impurities come from Synthetic peptides are assembled using a series of chemical reactions. For example, in solid-phase peptide synthesis, amino acids are added sequentially to an elongating chain. Coupling, deprotection, cleavage and purification all offer opportunities for the formation of related substances. Some originate in the starting materials. Others appear because a reaction does not proceed exactly as intended. Still others can develop later through degradation during processing or storage. Peptide-related impurities can include: Deletion sequences, where an expected amino acid is missing. Truncated sequences, where part of the intended chain is absent. Insertion sequences, containing an additional amino acid. Incompletely deprotected products, where a protecting group remains attached. Stereoisomers, including species formed through epimerization. Oxidized products, which can form when susceptible amino acid residues undergo oxidation. Hydrolysis and other degradation products that develop during processing or storage. Other synthesis-related by-products produced during coupling, cleavage or subsequent handling. Some of these molecules can be very similar to the intended peptide. A deletion sequence, for instance, may differ by only one amino acid. Stereoisomers can be harder still: they may have the same molecular formula and molecular mass while differing in spatial configuration. There is another category to consider. A peptide preparation can also contain non-peptide material, including counterions, residual water, residual solvents and process-related substances. These should not simply be treated as the “other 1%” of an HPLC result. Some may not be represented by that percentage in the same way as peptide-related chromatographic impurities. The impurity profile is not necessarily fixed once synthesis is finished. Some peptides can degrade during storage, with the extent and type of change depending on the sequence and conditions such as temperature, moisture and time. A purity result is therefore tied to the sample as it existed when it was analysed. How peptide purity is measured If the question is how to test peptide purity, RP-HPLC is one of the methods researchers encounter most often. The reason is practical: it can separate a target peptide from many related compounds and show their relative chromatographic signals. The sample is injected into the column and the components of the sample interact with the stationary phase differently as the solvent flows through it. Not all of them move at the same speed. As compounds leave the column, a detector measures the signal and produces the chromatogram. In the best case, the target peptide is the highest peak, and smaller peaks represent separated impurities or degradation products. The respective peak areas are integrated and a laboratory can report a result of 98.7% or 99.4%. This is the basic answer to how are peptides tested for purity by HPLC. There is a catch, though: a component has to be adequately separated and detected before it can appear as a distinct part of the result. The method can change what you see The same sample does not necessarily produce an identical purity figure under every chromatographic setup. Change the column, solvent gradient, temperature or detection conditions and the separation can change too. Sample preparation and the way peaks are integrated also matter. Peptides add another variable. Differences in sequence, charge and hydrophobicity affect how they behave during chromatography, so a method that separates one peptide cleanly may be less effective for another. Co-elution shows why this matters. An impurity can leave the column at nearly the same time as the target peptide. If the method cannot resolve the two signals, they may overlap instead of appearing as clearly separate peaks. Equal amounts of different compounds may not give equal signals under the same detection conditions. These variables are important in determining how to test peptide purity, because the value of the result depends on how well the method resolves the target peptide from relevant impurities. For that reason, how to test purity of peptides is partly a question of method suitability. Running an HPLC analysis is not enough on its own; the method has to separate and detect the components relevant to the sample. Purity and identity answer different questions A large main HPLC peak tells you about chromatographic composition. It does not, by itself, establish that the peak is definitely the peptide you expected. Mass spectrometry looks at the sample from another angle. It measures mass-to-charge ratios, allowing researchers to compare the observed molecular mass with the mass expected for a particular peptide. Chromatography and MS can also be combined. In LC-MS, compounds are first separated chromatographically and then examined by mass spectrometry. This makes the technique useful when researchers need to investigate the target peptide alongside related impurities. More detailed MS analysis can help characterize deletion or insertion sequences, modifications and degradation products. There are limits here as well. Some structural or stereochemical variants can share the same molecular mass, so mass alone may not distinguish them. HPLC and MS therefore contribute different pieces of information. HPLC shows how components separate chromatographically and supports a relative purity measurement; MS adds molecular-mass information that can support identification and impurity characterization. It’s easy to miss this distinction when you see claims of 99 pure peptides. The HPLC percentage is useful information but not the whole story about what is in the material or whether the main peak has been correctly identified. 99% purity does not mean 99% peptide content Say a lyophilized research peptide sample returns at 99% HPLC purity. This is not to be taken to mean 99 mg of target peptide per 100 mg of material. The vial